Researchers have found that the body's own immune system may be driving the progression of ALS, with immune cells attacking a protein found in neurons and triggering inflammation. The findings could lead to therapies that target the immune system, and may have implications for the treatment of other neurodegenerative diseases such as Alzheimer's and Parkinson's. Icahn School of Medicine at Mount Sinai Associate Professor of Neurology Dr. Fanny Elahi believes that diseases such as Alzheimer's may even be affecting women more frequently due to midlife physiological transitions, like menopause. However, according to Dr. Elahi, using blood biomarkers might help "detect risk of future symptoms with increasingly better predictive ability." She joined Carol Massar and Tim Stenovec on 'Bloomberg Businessweek Daily' to discuss Alzheimer's and other neurodegenerative diseases. (Source: Bloomberg)